Abstract
By using comparative genomic hybridization (CGH), we characterized the genetic profiles of 36 VHL-related pheochromocytomas. We then compared the results with those of sporadic and MEN 2-related pheochromocytomas. In 36 VHL-related tumors, loss of chromosome 3 and chromosome 11 were found in 34 tumors (94%) and 31 tumors (86%), respectively. There was significant concordance of deletions in chromosomes 3 and 11 (Kappa=0.64, P=0.0095), suggesting that they are involved in two different but necessary and complementary genetic pathways. The loss of chromosome 11 appeared to be specific for VHL-related pheochromocytoma as it was not present in any of the 10 VHL-related CNS hemangioblastomas studied and was significantly less common when compared with (a) sporadic pheochromocytomas from previously published results (13%; P=<0.0001), and (b) MEN 2-related pheochromocytomas from this and previously published studies (30%; P=0.0012). In summary, this is the first report of a novel consistent genetic alteration that is selected and specific for VHL-related pheochromocytoma, besides the two hits of the VHL gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baysal BE, Ferrell RE, Willett-Brozick JE, Lawrence EC, Myssiorek D, Bosch A, van der Mey A, Taschner PEM, Rubinstein WS, Myers EN, Richard CW III, Cornelisse CJ, Devilee P, Devlin B . 2000 Science 287: 848–850
Bender BU, Gutsche M, Gläsker S, Müller B, Kirste G, Eng C, Neumann HPH . 2000 J. Clin. Endocrinol. Metab. 85: 4568–4574
Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ, Robinson BG . 2000 Cancer Res. 60: 7048–7051
Brauch H, Kishida T, Glavac D, Chen F, Pausch F, Hofler H, Latif F, Lerman MI, Zbar B, Neumann HPH . 1995 Hum. Genet. 95: 551–556
Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A . 1996 Cancer Res. 56: 3331–3337
Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JR, Orcutt ML, Duh FM, Glenn G, Green J, Hsia YE, Lamiell J, Li H, Wei MW, Schmidt L, Tory K, Kuzmin I, Stackhouse T, Latif F, Linehan WM, Lerman M, Zbar B . 1995 Hum. Mutat. 5: 66–75
Dannenberg H, Speel EJM, Zhao J, Saremaslani P, van Der Harst E, Roth J, Heitz PU, Bonjer HJ, Dinjens WNM, Mooi W, Komminoth P, de Krijger RR . 2000 Am. J. Pathol. 157: 353–359
Edström E, Mahlamäki E, Nord B, Kjellman M, Karhu R, Höög A, Goncharov N, Teh BT, Kallioniemi O-P, Bäckdahl M, Larsson C . 2000 Am. J. Pathol. 156: 651–659
Farnebo F, Kytöla S, Teh BT, Dwight T, Wong FK, Höög A, Elvius M, Wassif W, Thompson NW, Farnebo L-O, Sandelin K, Larsson C . 1999 J. Clin. Endocrinol. Metab. 84: 3775–3780
Fearon ER, Vogelstein B . 1990 Cell 61: 759–767
Gimm O, Armanios M, Dziema H, Neumann HP, Eng C . 2000 Cancer Res. 60: 6822–6825
Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Goldberg MA . 1996 Proc. Natl. Acad. Sci. USA 93: 10595–10599
Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D . 1992 Science 258: 818–821
Kamura T, Koepp DM, Conrad MN, Skowyra D, Moreland RJ, Iliopoulos O, Lane WS, Kaelin Jr WG, Elledge SJ, Conaway RC, Harper JW, Conaway JW . 1999 Science 284: 657–661
Kwabi-Addo B, Girl D, Schmidt K, Podsypanina K, Parsons R, Greenberg N, Ittmann M . 2001 Proc. Natl. Acad. Sci. USA 98: 11563–11568
Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi P, Walther MM, Weng Y, Duan DS, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI . 1993 Science 260: 1317–1320
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ . 1999 Nature 399: 271–275
Ramus SJ, Bobrow LG, Pharoah PD, Finnigan DS, Fishman A, Altaras M, Harrington PA, Gayther SA, Ponder BA, Friedman LS . 1999 Genes Chromosomes Cancer 25: 91–96
Schussheim DH, Skarulis MC, Agarwal SK, Simonds WF, Burns AL, Spiegel AM, Marx SJ . 2001 Trends Endocrinol. Metab. 12: 173–178
Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ, Crook T . 1999 Oncogene 15: 2451–2459
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lui, W., Chen, J., Gläsker, S. et al. Selective loss of chromosome 11 in pheochromocytomas associated with the VHL syndrome. Oncogene 21, 1117–1122 (2002). https://doi.org/10.1038/sj.onc.1205149
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205149
Keywords
This article is cited by
-
Identification of genomic aberrations in hemangioblastoma by droplet digital PCR and SNP microarray highlights novel candidate genes and pathways for pathogenesis
BMC Genomics (2016)
-
Integrative analysis of neuroblastoma and pheochromocytoma genomics data
BMC Medical Genomics (2012)
-
Malignant pheochromocytomas and paragangliomas: a diagnostic challenge
Langenbeck's Archives of Surgery (2012)
-
Molecular Cytogenetic Characterization in Four Pediatric Pheochromocytomas and Paragangliomas
Pathology & Oncology Research (2011)
-
MicroRNA expression profiling in benign (sporadic and hereditary) and recurring adrenal pheochromocytomas
Modern Pathology (2010)